Phathom Pharmaceuticals, Inc. (PHAT): Weighted Average Diluted Shares

Annual figures by period end, from SEC filings.

72.92M
Year ended 2025-12-31
+23.1%
3-year compound annual growth
2021-12-31: 37.00M2022-12-31: 39.12M2023-12-31: 51.29M2024-12-31: 63.18M2025-12-31: 72.92M72.92M
2021-12-31 Weighted Average Diluted Shares (shares) 2025-12-31
Period endedWeighted Average Diluted SharesChange YoYSource filing
2025-12-3172.92M+15.4%2026-02-26, From 2025-01-01
2024-12-3163.18M+23.2%2026-02-26, From 2024-01-01
2023-12-3151.29M+31.1%2025-03-06, From 2023-01-01
2022-12-3139.12M+5.7%2024-06-14, From 2022-01-01
2021-12-3137.00Mn/a2023-02-28, From 2021-01-01